" 601.32 
general factors relevant to safety and effectiveness. 
fda's determination of the safety and effectiveness of a diagnostic radiopharmaceutical includes consideration of the following: 
(a) the proposed use of the diagnostic radiopharmaceutical in the practice of medicine; 
(b) the pharmacological and toxicological activity of the diagnostic radiopharmaceutical (including any carrier or ligand component of the diagnostic radiopharmaceutical); and 
(c) the estimated absorbed radiation dose of the diagnostic radiopharmaceutical.", 
